Skip to Main Content

Major drug makers are getting into mRNA, the technology behind the Moderna and Pfizer-BioNTech Covid vaccines, in a big way.

Sanofi, one of the largest vaccine makers, announced Tuesday it will spend $3.2 billion to purchase Translate Bio, its partner in an effort to create an mRNA-based Covid-19 vaccine. That follows a June announcement that Sanofi would create an mRNA vaccines center of excellence, funded with almost $500 million annually, with the goal of creating six experimental vaccine candidates by 2025.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

Create a display name to comment

This name will appear with your comment